thesi broken downgrad hold buy pt
 downgrad share hold buy
lower pt prior buy thesi need
one two thing true gener book
necessari meet mid-point guidanc
would sell netsmart stake proce use buy-back
share appear former longer true weak
book management talk low-end guidanc
latter risk deal complex valuat may prevent
accept offer lack posit move
back sidelin hold sandi draper
clinic program discontinu downgrad hold
surpris learn discontinu due
lack efficaci compani second gene therapi program
also affect given employ aav
capsid preclin data wamd
promis compani track initi phase studi
see limit near-term catalyst boost share valu
downgrad hold lower pt
curi inc cri buy plan streamlin
clinic develop look forward follow curiss
recent chang ceo sept new ceo jim dentzer present
compani plan streamlin clinic developmentfocus
fimepinostat particular order
prioriti manag reiter data albeit
unlik show robust respons rate help underlin
move focu vista-posit cancer guid toward
initi data new trial set enrol
reiter buy rate lower pt princip
lower cash peter lawson
result line pre-releas result disclos
equiti offer although inap posit surpris
announc nearli mw coloc deal dalla
simultan cut mid-point guidanc rang
impli littl sequenti growth time investor
like expect continu improv close
equiti offer guide-down like reason
increment share price downdraft over-react
opinion maintain buy rate reduc target
tantal opportun crystal reiter buy
 result solid revenu come top-end
rais guidanc analyst day revenu guidanc
rais remaind although kept
model unchang think longer term
outlook continu improv specif address
earn call expect cross-sel opportun
hit stride best doc adv medic
prospect regul loosen medicar adv reimburs
telemedicin think could place live
still await win rule reit buy although came
short street expect encourag
see manag continu sourc deal
diversifi revenu expect win rule come
manag abl achiev diversif target
next year maintain buy rate believ
benefit posit outcom win case expect
fiber segment recov recent hiccup greg
solid launch tibsovo aml updat
encourag initi sale tibsovo r/r aml
vs consensu better preview
rais fy estim
tibsovo encourag
initi uptak tone manag around initi launch
metric posit end-point chang potenti
move tibsovo/idhifa front line plu data
toward tki choic rcc continu expand market
 cabozantinib achiev anoth strong quarter mn
revenu beat consensu mn repres
q/q revenu growth q/q share growth tki rcc
market movement toward becom tki choic
rcc compani pdufa date cabozantinib
liver cancer jan partner ipsen otcmkt
ipsey nr possibl eu approv liver cancer
reiter buy rate pt peter lawson
zejula upsid like come emerg io
pipelin encourag sale zejula
ovarian cancer mainten set vs consensu
better preview
compani rais zejula revenu street
rais fy estim zejula
encourag on-going strong launch
europ tone manag around market share
us posit upcom data updat
regulatori file parp prostat io
endometri reiter pt peter lawson
page
 ga posit bcf vs bberg bcf
retail reit groceri e-commerc adopt set acceler
result revenu expect better-than-
expect margin perform drive adjust ebitda
expect traffic growth continu improv
increas concern long-term growth prospect
net centric busi implic revenu growth
though think sd-wan offer signific long-term growth
opportun dividend continu step
sd-wan ramp believ overal top-lin perform
restrain premium valuat maintain hold rate
pt greg miller
guidanc bump momentum build buy
 deliv solid result view though
still complic variou acquisit move
part manag rais guidanc well addit
manag announc signific increas develop
pipelin extend broadli across eqix geograph
footprint includ project expand recently-acquir data
center verizon itcon overal see continu
execut believ see acceler normal
constant-curr growth improv margin acceler
affo growth maintain buy trim target greg miller
demonstr european market begun final
trace growth us market wit two
year ago still-smal world market think europ
signific room expand exampl note ytd
absorpt northern virginia alon exce europ
given except strong competit posit track
record execut think inxn grow least
increas confid acceler revenu growth
margin expans reiter buy rate greg miller
posit growth despit late cycl concern updat
estim follow result ebitda goe
ebitda goe
price target goe base
multipl previous blend sotp
continu improv still earli make call tx
maintain hold pt compstore improv
meaning vs consensus-match estimate
beaten estim consecut
quarter re-focus core hispan consum
famili meal recent simplifi menu tx store appear
stabil sale believ far earli becom
page
construct unit growth opportun tx
non-cor market happen expect lt unit growth
constrain limit multipl expans
increas est pt jake bartlett
miss/guid overshadow ceo departur barri
 shi weighti expect lower ests/pt
 lower estim pt vs
acknowledg n-t visibl bit cloudi
wtw execut multitud initi l-t thesi
unchang still believ compani post ep
growth maintain buy michael swartz
intact expect neg compstore limit nt upsid lower
pt report better expect adj ebitda
vs estimate consensu
compstore miss vs estimate consensu
guidanc incorpor continu weak driven
sale cannib new store unit growth
stori remain compel new unit volum much better
expect compani store sale beat consensu
despit compstore miss strong develop guidanc
maintain buy rate expect limit near-term upsid
compstore move posit earli lower est pt
 guidanc light fundament still intact post
miss pro-forma guidanc expect adj ebitdar
model revenu competit
pressur il ms drove miss region remain
healthi pro-forma guidanc model
adjust deal time net net think thesi
remain larg intact pnk integr yield upsid
estim fulli explor adjust
ebitdar reflect guidanc deal time
conserv assumpt ms/il lake charl pt
maintain buy barri jona
littl patienc need dam break follow
result lower ebitda
estim slightli respect
initi ebitda estim
maintain price target equat
ebitda includ inventori slight premium
peer continu believ monet compani
inventori allow compani reach sustain ep
level least reiter buy william chappel
page
result updat guidanc maintain
ep estim respect
initi ep estim rais price
target equat ep
premium peer reiter buy william chappel jr
maintain pt maintain
estim pt good qtr expect
benefit pg acquisit larg neutral cost/fx
headwind year ahead buy michael swartz
inc buy like
progress loan loss provis stepped-up share repurchas
 updat estim take adjust ebitda
estim adjust ebitda
estim adjust ep
estim go estim
lower price target price
target base multipl
lower guidanc lower
adjust ep estim
respect also initi ep estim
ep beat nice see believ focu
stori remain potenti earn recoveri
maintain price target equat
ep estim in-lin peer maintain hold
electr power util
base updat assumpt reduc
estim increas estim ali agha
 earn trend keep compani track full
year outlook appear attract price p/
 multipl discount us util peer group base
price follow encana lead go forward
announc encana eca nr acquisit newfield
morn weve adjust estim includ third
quarter actual though maintain price target
expect share trade line encana share
page
expect deal close continu monitor sharehold
sentiment relat transact given impli price/
share vs nfx previou trade rang reiter hold
rate price target wait sharehold
first close four sale middl east
reclaim margin safeti statu pt
report in-lin see note howev overshadow
updat compani disclos drill nearli
acreag even prop pass drive today
out-performance see feel today move like
indic return safe wattenberg name
room left run stock trade nearli pt
prop made ballot continu favor
insul low-multipl way play co elect
believ pass think allow
nobl inc buy vision
yield acceler activ
repurchas program reiter see note call
focus abil navig co elect result
transit row develop delawar execut
e-m project sound dedic share repurchas
program expect acceler start
shift substanti profil like apc hold /srci
buy indic industri laser focus prevent
recurr setback ballot hit stride
look continu banner year
energi inc buy eye
fundament remain highli attract srci in-
line given pre-released see note would expect
guidanc vote dcp midstream dcp
nr pressur improv push ahead
connor mmcf/d horn
mmcf/d match heard buy
buy encourag would clear runway
note cohes industri go
offens post elect feel post wattenberg could
back true form quickli well fitzpatrick
reiter guidanc ceo step neal
strength midstream simplif fuel buyback last
night ar turn slight beat improv rate
marcellu utica minim pull forward capital-expenditure
page
due faster expect drill pace see note given
recent strength ngl price good amount call focus
ar abil leverag larg liquid compon
start compani shift stand-alon
profil start quarter potenti cash proce
midstream simplif transact would
expect ar execut materi share repurchas program
 well fitzpatrick
expect blurri line sight sn seem approach
quarter intent re-set investor expect
sever qtr well underperformance/oper issu
sn take step get back growth-mod question
time need slowdown comanch activ
discuss despit price tag upcom activ
focus toward catarina perhap packag all/part
comanch sn allud willing divest all/part
asset er side caution oper
issu clear up/cost come product begin
w/ impress well includ best permian
view acreag management best smid cap
howev plan continu call growth/outspend
forecast caus leverag remain higher average fear
capit rais benefit blm spend seen
permit take yr view deal
accret long term less near-term despit all-star oper
 stock favor mani investor remain hold
coupl overhang closer resolut neal
inc buy soon gener
annual quarterli time asid remain
track strong program set sever quarter ago
ultim could result massiv compani reiter
guidanc provid capit plan maintain
strong oil growth hold activ rel steadi
continu bring strongest industri williston
delawar basin well includ bone spring permian
well provid increment tier inventori meet
sub leverag goal compani close
goal forecast drive neal
 week bcf inject posit versu
bloomberg consensu bcf inject pleas see tabl
accompani graph detail addit pleas
page
see ga storag preview note yesterday well
follow upsid boost oper ep
estim reflect upsid along
outlook higher invest margin lower tax rate
estim goe rais
forecast reiter buy rate
base outlook grow asset faster
peer also gener meaning higher return
trim price target previous book
reflect recent multipl compress across life insur
heritag begin put issu behind reiter buy
 rais ep estim
reflect upsid well outlook improv
sequenti also bump forecast
heritag appear make progress
fraud issu challeng florida carrier oper
expens downward trajectori hurrican
season wind reiter buy rate price
target next year earn trade
substanti discount florida peer broader specialti
thesi broken downgrad hold buy pt
 downgrad share hold buy
lower pt prior buy thesi need
one two thing true gener book
necessari meet mid-point guidanc
would sell netsmart stake proce use buy-back
share appear former longer true weak
book management talk low-end guidanc
latter risk deal complex valuat may prevent
accept offer lack posit move
back sidelin hold sandi draper
clinic program discontinu downgrad hold
surpris learn discontinu due
lack efficaci compani second gene therapi program
also affect given employ aav
capsid preclin data wamd
promis compani track initi phase studi
see limit near-term catalyst boost share valu
page
downgrad hold lower pt
tantal opportun crystal reiter buy
 result solid revenu come top-end
rais guidanc analyst day revenu guidanc
rais remaind although kept
model unchang think longer term
outlook continu improv specif address
earn call expect cross-sel opportun
hit stride best doc adv medic
prospect regul loosen medicar adv reimburs
telemedicin think could place live
solid launch tibsovo aml updat
encourag initi sale tibsovo r/r aml
vs consensu better preview
rais fy estim
tibsovo encourag
initi uptak tone manag around initi launch
metric posit end-point chang potenti
move tibsovo/idhifa front line plu data
curi inc cri buy plan streamlin
clinic develop look forward follow curiss
recent chang ceo sept new ceo jim dentzer present
compani plan streamlin clinic developmentfocus
fimepinostat particular order
prioriti manag reiter data albeit
unlik show robust respons rate help underlin
move focu vista-posit cancer guid toward
initi data new trial set enrol
reiter buy rate lower pt princip
lower cash peter lawson
toward tki choic rcc continu expand market
 cabozantinib achiev anoth strong quarter mn
revenu beat consensu mn repres
q/q revenu growth q/q share growth tki rcc
market movement toward becom tki choic
rcc compani pdufa date cabozantinib
liver cancer jan partner ipsen otcmkt
ipsey nr possibl eu approv liver cancer
reiter buy rate pt peter lawson
zejula upsid like come emerg io
pipelin encourag sale zejula
ovarian cancer mainten set vs consensu
better preview
compani rais zejula revenu street
rais fy estim zejula
page
encourag on-going strong launch
europ tone manag around market share
us posit upcom data updat
regulatori file parp prostat io
endometri reiter pt peter lawson
remain bullish molina follow anoth banner mark
on-going expens control meaning guidanc rais
addit capit structur improv shape
anoth strong year reiter buy rate
 take abstract
qure impress initi data
next-gener product candid relapsed/refractori
multipl myeloma r/r mm sickl cell diseas scd
view meta-analysi support gbt effort get voxelotor
goal-lin via acceler approv differ
one-stag chromogen assay underscor import
look beyond factor level gene therapi hemophilia
long-term data qure could shed light
durabl liver-direct gene transfer product edward
reiter buy ci follow strong result mark
top bottom line beat better mcr full year medic cost
trend lower rais guidanc
esrx acquisit continu track toward close
continu like deal tie number expect
benefit view power combin offer
score improv see ci teed strong
beyond reiter buy pt
excit remain bullish follow solid
result mark superb organ trend afam integr
progress continu improv qualiti score reiter
full year guidanc addit cash flow robust jv
ramp jv/m pipelin full continu view
fundament compel sever risk/valu
base payment model pilot underway see compani
well posit capit sizabl ma/manag care
opportun time reiter buy price target
maintain hold rate follow challeng quarter mark
sluggish neonat volum modest anesthesia payor mix
degrad soft guidanc volum trend
radiolog anesthesia remain intact operational/effici
page
initi make headway overal environ remain
challeng solid cash flow potenti aid propos
meddata sale view compani well posit deploy
capit help augment underli busi maintain
cohort show promis progress
pfizer inc hold postviewreturn
revenu growth heavili depend pipelin
execut lower sale vs pfe
midpt street rais ep vs pfe
rang street face challeng
environ due ih price compress
eh model sale growth despit
growth heavili pipelin depend
diseas oncolog increment revenue
nme well-posit re-evalu large-scal
room debt attract multipl equiti
maintain ep support dcf
strong result demonstr continu oper
focu along accru benefit acquisit strategi
regulatori environ look less burdensom
improv reimburs outlook remain well
posit continu robust growth despit strong
ytd stock perform maintain bullish outlook
anticip on-going benefit across portfolio
improv transit facil perform increment
acquisit opportun reiter buy rate rais
pt ebitdar eric fleme
remain posit slope progress appear less steep
pt hold see fundament question
underpin estim extent overcom
well replacement- consolidation- driven demand
recent book momentum suggest crack
growth equat attrit surpris upsid
increment revenu mix continu pressur margin
lower estim pt reflect expect slower
pace progress -- still upward trajectori -- revenu ep
growth remain sidelin given limit upsid
orr maintain combo encourag peter lawson
page
beat rang lower oncolog sale
rais adjust ep estim
respect move
price target reflect lower target multipl
ebitda estim histor
forward averag multipl one standard deviat
 charl bradi
manag price/cost robust demand environ
rais adjust ep estim
adjust ep estim unchang
adjust ep move price target
remain reflect multipl ebitda
improv renew confid rais
adjust ep estim
adjust ep estim also increas
respect price target remain
reflect target ev/ebitda multipl half
turn lower prior target multipl histor
forward averag multipl one standard deviat
growth rais adjust ep
estim respect
adjust ep estim also increas
rais price target
repres unchang multipl ebitda
estim histor forward averag multipl one
standard deviat charl bradi
still issu drop revenu revenu result
particularli good given fear home build continu
lack pass product inflat impact gross margin
metric quarter row
improv near-term margin pressur expect
lack progress year substanti disappoint
lower estim result stock
 releas nonetheless entir
group oversold expect ralli continu
page
notabl lower price target home build controversi
 guid lower due softer demand asia earn
resili fx headwind rise raw materi pressur
howev guid lower due weaken trend asia
increment cautiou organ growth prospect
given weaken demand trend pah higher-margin
electron assembl circuit board segment
lower pt reflect lower peer valuat
macro headwind pah exhibit stabl
gener profil post divestitur arysta set close
year end upsid valuat pf
inc buy legaci
acquisit drive strong growth margin
roughli far stronger expect sale
earn robust storm relat sale led
organ growth manag rais guidanc
importantli outlook maintain solid organ growth despit
tough comp demand florida hurrican
could come maintain buy rate
increas price target keith hugh
 beyond buy icf track grow major end
market sever present opportun meaning
work public health compani sale attribut
rise feder budget opioid abus commerci
busi energi effici work electr util
anticip signific upward revis puerto
skeptic buy reiter buy pt
ebitda view materi under-valued investor
underestim valu allpoint network grow
effici global estat assert stronger-than-expect
surcharg brand think l-t opportun monet
allpoint via manag servic next growth leg
model new revenue ebitda est
prior
street
page
appreci increment hold maintain hold drop
pt ebitda believ co
hold challeng competit environ
flex brand muscl belatedli lower px emphas
electron offer beleiv effort enough
acceler organ revenue growth toward market rate
result profit like remain mute
share opinion new rev/ebitda est
prior
street
contract growth highlight see past quarter well-
round perform character signific
contract award growth construct demand environ
believ guidanc increas driven improv
oper expect follow quarter result
posit impact part unexpect time fee
associ transit new account standard
increas adjust ebitda estim
follow recent volatil stock price lower
pt maintain hold rate tobey sommer
inc buy strength
analyt invest consult digit reiter
buy view short term revenu volatil certain segment
off-set continu steadi growth analyt addit
invest consult digit could drive revenu
margin go forward firm analyt segment continu
post solid growth year year organ basi
includ acquisit drive sustain
revenu adjust near term estim slightli
narrow revenu guidanc establish ep
sever ceo founder compani
sprout axlehir simplista also attend inaugur
groceryshop confer la vega dedic
grow groceri e-commerc industri want share
park hotel resort inc pk buy essenti
line guid basic unchang patrick schole
in-line affo/shar ebitda
mgp tripl net leas model stabl secur leav
surpris earn tweak model
quarter major chang forward estim manag
note market remain robust discuss around
page
springfield rofo could start remain hold rate
valuat price target barri jona
game leisur properti inc buy
in-line ebitda affo/shar
model/guid note triple-net reit result typic
stabl littl store variabl tweak estim
reflect guidance/d fund detail materi chang
ebitda estim see compel valuat stori
trade materi discount peer despit secur
rent stream healthi dividend growth share
today due part slight miss though see risk
rent payment healthi coverag reiter buy barri
apart invest manag compani
momentum michael lewi
driven outsid room spend patrick schole
expect ssrev momentum despit oregon weak
fairli price stock view rais core
ffo estim slightli maintain pt
impli return achiev strongest yoy same-
store revenu growth seven-compani pure apart
rang outcom group appear fairli narrow
like price target impli rel
modest upsid keep hold rate stock
could becom construct pullback
stock price sign materi underestim
 complet median jv along select
portfolio disposit meaning reduc leverag
enviabl posit deploy signific
swap master leas solid coverag bolster
outlook add manag ffo guidanc
assum invest activ look forward
anoth activ year reiter buy rate pt
miss gener lower guidanc although nois
tax labor strike patrick schole
quarter deal activ strong guidanc ki bin
page
result revenu expect better-than-
expect margin perform drive adjust ebitda
expect traffic growth continu improv
increas concern long-term growth prospect
net centric busi implic revenu growth
though think sd-wan offer signific long-term growth
opportun dividend continu step
sd-wan ramp believ overal top-lin perform
restrain premium valuat maintain hold rate
pt greg miller
guidanc bump momentum build buy
 deliv solid result view though
still complic variou acquisit move
part manag rais guidanc well addit
manag announc signific increas develop
pipelin extend broadli across eqix geograph
footprint includ project expand recently-acquir data
center verizon itcon overal see continu
execut believ see acceler normal
constant-curr growth improv margin acceler
affo growth maintain buy trim target greg miller
result line pre-releas result disclos
equiti offer although inap posit surpris
announc nearli mw coloc deal dalla
simultan cut mid-point guidanc rang
impli littl sequenti growth time investor
like expect continu improv close
equiti offer guide-down like reason
increment share price downdraft over-react
opinion maintain buy rate reduc target
demonstr european market begun final
trace growth us market wit two
year ago still-smal world market think europ
signific room expand exampl note ytd
absorpt northern virginia alon exce europ
given except strong competit posit track
record execut think inxn grow least
increas confid acceler revenu growth
margin expans reiter buy rate greg miller
still await win rule reit buy although came
page
short street expect encourag
see manag continu sourc deal
diversifi revenu expect win rule come
manag abl achiev diversif target
next year maintain buy rate believ
benefit posit outcom win case expect
fiber segment recov recent hiccup greg
maint buy earn maintain pt
expect strong line street expect
compani report tuesday busi
cost like show godaddi fundament remain
healthi expect get updat main street hub
integr competit landscap opportun along
increment progress toward lt goal growth/profit
laid analyst day nave khan
optimist payoff sale product
invest solid upsid highlight seventh
straight quarter recur revenu grow
rang strong profit margin upsid offset
revenu in-lin adjust ebitda guidanc conserv
optimist emerg growth opportun
market product expans like drive continu
strong arpu trend reiter buy rais price target
slightli higher revenu estim terri tillman
in-line fx like increment headwind expect
larg in-lin report monday
analysi data indic room night growth
qtr like come at/modestli management guidanc
broadli in-line street expect expect room night
show sequenti improv compani anniversari
last year cut meta search analysi currenc
movement point increment headwind fx
financi nave khan
busi trends/outlook expect report in-line
result wed mute growth hotel
segment strong growth non-hotel help strength
attract restaur expect see progress
mobil shopper monet view on-going audienc mix-
shift mobil continu pull back market
spend headwind hotel revenu growth read-
trvg posit
view believ trend key busi metric management
commentari outlook key stock nt
maint pt nave khan
page
hold compani announc posit result across
subscript total revenu ep defer revenu
flow came slightli short expect yet guidanc
remaind year revenu oper incom
well consensu estim view appian
leader innov low-cod develop platform go
larg market opportun stock trade
line softwar growth peer without notabl near-
term catalyst maintain hold rate terri tillman
macro caution cost save buyback protect ep
buy revenu growth remain risk cost save
capit alloc preserv earn buy nxpi beat
provid mix outlook beat ep buyback
expect cycl continu present sale headwind
opex control buyback preserv earn despit
contempl addit cyclic weak model
estim go partli cost save larg buyback
ep goe ep goe
pt goe base
ep line mcu peer william stein
inc hold better
fear concern remain result guidanc good enough
tariff/macro impact may around corner hold
deliv beat guidanc light
ep owe weak system mix result guidanc
appear better fear believ compani may see
tariff/macro bit later semi supplier keep us
sidelin ep goe
ep goe pt goe base
ep discount hold
guidanc rate headwinds/valu keep us sidelin
 virtual line quarter better fear upwardli
revis outlook acquisit larg short posit
float help spark relief ralli today maintain
hold adjust pt rise rate tough y/
comp creat greater headwind
key product management diversif strategi help mitig
much pressur valuat deceler organ growth
keep us neutral operational/financi scale
consolid person digit help
board maintain hold/pt
anoth uninspir quarter top line management
labor re-energize/stabil revenu growth
time although cost contain appear work
similar growth vbu slightli
weaker expect management commentari suggest trend
page
like persist short-term longer term expect
high-singl digit/low doubl digit growth still two
segment respect adjust est pt
ebitda view
page
inc group meet cfo evp global custom oper san jose
shutterfli inc ndr president/ceo vice-president ir treasuri boston
ring inc ndr ceo director presid director mid-west boston
polyon corp ndr cfo vice-president ir canada boston
fti consult inc fti ndr ceo manag director ir corp lo angel
inc ndr cfo global vice-president financ ir boston
nabriva therapeut plc nbrv ndr cfo vice-president corpor control head ir texa
suntrust bank inc sti ndr co-chief oper offic director ir assist treasur ir
keyw hold corp keyw ndr ceo ir treasur mid-west
 ndr evp cfo princip account offic treasur vice-president ir
inc group meet ceo cfo west coast
inc ndr ceo cfo vice-president strateg financ boston new york
inc ndr cfo director ir denver kc
navig consult inc nci ndr ceo cfo director ir kc tx
page
nov lodg game leisur summit boston
dec estimate conf call boston lodg takeaway
andrew jeffrey oscar turner transact process boston
mark hugh insur new york boston
jennif demba michael young- bank southeast
dec jennif demba michael young- bank west coast
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
